Probing the Probes: Fitness Factors For Small Molecule Tools
Top Cited Papers
Open Access
- 24 June 2010
- journal article
- review article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 17 (6), 561-577
- https://doi.org/10.1016/j.chembiol.2010.05.013
Abstract
Chemical probes for interrogating biological processes are of considerable current interest. Cell permeable small molecule tools have a major role in facilitating the functional annotation of the human genome, understanding both physiological and pathological processes, and validating new molecular targets. To be valuable, chemical tools must satisfy necessary criteria and recent publications have suggested objective guidelines for what makes a useful chemical probe. Although recognizing that such guidelines may be valuable, we caution against overly restrictive rules that may stifle innovation in favor of a “fit-for-purpose” approach. Reviewing the literature and providing examples from the cancer field, we recommend a series of “fitness factors” to be considered when assessing chemical probes. We hope this will encourage innovative chemical biology research while minimizing the generation of poor quality and misleading biological data, thus increasing understanding of the particular biological area, to the benefit of basic research and drug discovery.Keywords
This publication has 143 references indexed in Scilit:
- Rationalizing the chemical space of protein–protein interaction inhibitorsDrug Discovery Today, 2010
- The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitorsNature Chemical Biology, 2010
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFCell, 2010
- HTS and hit finding in academia – from chemical genomics to drug discoveryDrug Discovery Today, 2009
- Predicting new molecular targets for known drugsNature, 2009
- Measuring and interpreting the selectivity of protein kinase inhibitorsJournal of Chemical Biology, 2009
- Lead-like, drug-like or “Pub-like”: how different are they?Journal of Computer-Aided Molecular Design, 2007
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- Initial sequencing and analysis of the human genomeNature, 2001